Netwrix Is Recognized as a Visionary in the 2023 Gartner® Magic Quadrant™ for Privileged Access Management

Netwrix, a cybersecurity vendor that makes data security easy, has been recognized as a Visionary in the 2023 Gartner Magic Quadrant for Privileged Access Management.

Netwrix Privilege Secure reduces an organization’s attack surface and prevents lateral movement by replacing risky privileged accounts with ephemeral ones that grant the minimum access required and exist only as long as needed. Additionally, Netwrix Privilege Secure, with its real-time account visibility, helps eliminate privilege account sprawl and ensure a least privilege approach for endpoints, enabling end-to-end security for privileged access. Alternatively, the solution can enrich an existing PAM vault.

Netwrix’s recent annual security report revealed that more than a third (36%) of organizations with cyber insurance had to have a PAM solution in order to qualify for the policy and reduce the chance of a data breach. We believe that the recognition of Netwrix as a Visionary by Gartner in its Magic Quadrant for Privileged Access Management demonstrates our commitment to addressing the pressing security concern of locking down privileged access.
Michael Tweddle, Chief Product Officer at Netwrix

Gartner, Magic Quadrant for Privileged Access Management, Felix Gaehtgens, James Hoover, Michael Kelley, Brian Guthrie, Abhyuday Data, 5 September 2023.

GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.